tak 779 Search Results


94
MedChemExpress tak 779
Blocking SASP-related CCL5 inhibits the migration ability induced by Palbociclib. (a) The effect of antagonists of <t>CCR5</t> <t>TAK-779</t> on the migration ability of NSCLC cells treated with 2 μ M Palbociclib. Upper: Images of migrated cell with Palbociclib or TAK-779, bar: 100 μ m. Lower: The results were analyzed using unpaired t -test. (b) Diagram showing how Palbociclib contributes to the migration and invasion of NSCLC via SASP-related CCL5.
Tak 779, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tak+779/TAK-779/pmc10175017-33-3-7
Average 94 stars, based on 1 article reviews
tak 779 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

N/A
TAK-779(Cat No.:I002746)is a potent, selective antagonist of the CCR5 chemokine receptor, known for its role in blocking HIV entry into host cells. By inhibiting the binding of the virus to CCR5, a key co-receptor for
  Buy from Supplier

92
Tocris tak 779
Blocking SASP-related CCL5 inhibits the migration ability induced by Palbociclib. (a) The effect of antagonists of <t>CCR5</t> <t>TAK-779</t> on the migration ability of NSCLC cells treated with 2 μ M Palbociclib. Upper: Images of migrated cell with Palbociclib or TAK-779, bar: 100 μ m. Lower: The results were analyzed using unpaired t -test. (b) Diagram showing how Palbociclib contributes to the migration and invasion of NSCLC via SASP-related CCL5.
Tak 779, supplied by Tocris, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tak+779/TAK+779/pm42814571-737-0-1
Average 92 stars, based on 1 article reviews
tak 779 - by Bioz Stars, 2026-10
92/100 stars
  Buy from Supplier

90
Verlag GmbH tak-779
Blocking SASP-related CCL5 inhibits the migration ability induced by Palbociclib. (a) The effect of antagonists of <t>CCR5</t> <t>TAK-779</t> on the migration ability of NSCLC cells treated with 2 μ M Palbociclib. Upper: Images of migrated cell with Palbociclib or TAK-779, bar: 100 μ m. Lower: The results were analyzed using unpaired t -test. (b) Diagram showing how Palbociclib contributes to the migration and invasion of NSCLC via SASP-related CCL5.
Tak 779, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tak+779/tak+779/10__1002_slash_chin__201492401-941-34-13
Average 90 stars, based on 1 article reviews
tak-779 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

tak  (Takeda)
86
Takeda tak
Blocking SASP-related CCL5 inhibits the migration ability induced by Palbociclib. (a) The effect of antagonists of <t>CCR5</t> <t>TAK-779</t> on the migration ability of NSCLC cells treated with 2 μ M Palbociclib. Upper: Images of migrated cell with Palbociclib or TAK-779, bar: 100 μ m. Lower: The results were analyzed using unpaired t -test. (b) Diagram showing how Palbociclib contributes to the migration and invasion of NSCLC via SASP-related CCL5.
Tak, supplied by Takeda, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/tak+779/779+tak/pm16319100-43-0-4
Average 86 stars, based on 1 article reviews
tak - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

N/A
TAK-779 (Takeda 779) is a potent and selective nonpeptide antagonist of CCR5 with Ki of 1.1 nM. TAK-779 is also a CXCR3 antagonist and an effective, selective inhibitor of R5 HIV-1 with EC50 and EC90
  Buy from Supplier

N/A
TAK-779 is an antagonist of chemokine receptor 5 (CCR5), CCR2b, and CXC chemokine receptor 3 (CXCR3).
  Buy from Supplier


N/A
TAK-779 is a potent, dual antagonist at chemokine receptors CCR2 and CCR5 with IC50 = 1.4 nM at CCR5 and 2.3 nM at CCR2. Antagonists of both CCR2 and CCR5 such as TAK-779 have been
  Buy from Supplier

N/A
TAK 779 is an antagonist of chemokine receptor 5 CCR5 CCR2b and CXC chemokine receptor 3 CXCR3 It inhibits CCR5 and CXCR3 ICs 236 and 369 nM respectively for mouse recombinant receptors expressed in 2B4
  Buy from Supplier

Image Search Results


Blocking SASP-related CCL5 inhibits the migration ability induced by Palbociclib. (a) The effect of antagonists of CCR5 TAK-779 on the migration ability of NSCLC cells treated with 2 μ M Palbociclib. Upper: Images of migrated cell with Palbociclib or TAK-779, bar: 100 μ m. Lower: The results were analyzed using unpaired t -test. (b) Diagram showing how Palbociclib contributes to the migration and invasion of NSCLC via SASP-related CCL5.

Journal: Journal of Oncology

Article Title: Palbociclib Enhances Migration and Invasion of Cancer Cells via Senescence-Associated Secretory Phenotype-Related CCL5 in Non-Small-Cell Lung Cancer

doi: 10.1155/2022/2260625

Figure Lengend Snippet: Blocking SASP-related CCL5 inhibits the migration ability induced by Palbociclib. (a) The effect of antagonists of CCR5 TAK-779 on the migration ability of NSCLC cells treated with 2 μ M Palbociclib. Upper: Images of migrated cell with Palbociclib or TAK-779, bar: 100 μ m. Lower: The results were analyzed using unpaired t -test. (b) Diagram showing how Palbociclib contributes to the migration and invasion of NSCLC via SASP-related CCL5.

Article Snippet: Antagonists of CCR5, TAK-779, was purchased from MCE (CA, USA).

Techniques: Blocking Assay, Migration